Clinical Trials Directory

Trials / Sponsors / Fondazione EMN Italy Onlus

Fondazione EMN Italy Onlus

Academic / Other · 20 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
WithdrawnMelflufen for Elderly Patients With Relapsed Myeloma
Relapse Multiple Myeloma
Phase 22025-03-26
CompletedPatient With MMRR Treated With Belantamab Mafotidine on Monotherapy
Multiple Myeloma
—2022-07-22
RecruitingA "Physician & Patient-powered" Cohort Registry (MY MYELOMA)
Multiple Myeloma
—2021-03-16
Active Not RecruitingA Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients
Multiple Myeloma, Deletion 17P Syndrome
Phase 22019-07-01
Active Not RecruitingA Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant
Multiple Myeloma, New Diagnosis Tumor
Phase 32019-07-01
TerminatedPom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance Trea
Multiple Myeloma
Phase 32016-02-18
CompletedDetection of Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients
Multiple Myeloma
—2015-11-26
CompletedSTUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN E
Multiple Myeloma
Phase 32014-07-01
CompletedCyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refract
Multiple Myeloma
Phase 22013-03-01
CompletedMonitoring of Deep of Response During Lenalidomide Maintenance in MM Patients Achieving at Least Very Good Par
Multiple Myeloma
—2013-03-01
CompletedPomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Ref
Multiple Myeloma
Phase 1 / Phase 22010-07-01
CompletedLenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednison
Multiple Myeloma
Phase 32009-10-01
CompletedCyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Ste
Multiple Myeloma
Phase 32009-07-01
CompletedSafety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma F
Multiple Myeloma
Phase 22008-09-01
CompletedRevlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients
Multiple Myeloma
Phase 22008-07-01
TerminatedDasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patie
Myeloma
Phase 22008-02-01
CompletedTotal Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation
HEMATOLOGIC MALIGNANCIES
N/A2007-11-01
CompletedLenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients
Multiple Myeloma, Newly Diagnosed Patients
Phase 32007-06-01
CompletedRMPT for Relapsed/Refractory Multiple Myeloma
Multiple Myeloma
Phase 22007-02-01
CompletedVelcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patie
Multiple Myeloma
Phase 32006-05-01